Boston Scientific CorporationBSXNYSE
LOADING
|||
PE Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-earnings ratio
Latest
70.89
↑ 10322% above average
Average (9y)
0.68
Historical baseline
Range
High:326.58
Low:-621.10
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 70.89 | +34.4% |
| 2023 | 52.73 | -44.4% |
| 2022 | 94.83 | +63.2% |
| 2021 | 58.10 | +109.4% |
| 2020 | -621.10 | -4739.2% |
| 2019 | 13.39 | -54.2% |
| 2018 | 29.21 | -91.1% |
| 2017 | 326.58 | +285.9% |
| 2016 | 84.63 | +182.6% |
| 2015 | -102.44 | - |